Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Alexandre Kiazand, MD

AstraZeneca

Disclosure(s): AstraZeneca: Employee, holds or may hold stock

Poster(s):

(P-1960) Safety and Pharmacokinetics of Long-acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442) are Consistent after Repeat Dosing: Results from the PROVENT Substudy

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT